HOME - News - Editorials
 
 
26 July 2024

Ostrow research team uncovers the underpinnings of head and neck cancers


Upper aerodigestive squamous cell carcinoma is a common and aggressive malignancy — it attacks more than half a million people each year, leaving them battling fatal tumors in the airways of the head and neck. Even with so many individuals impacted, there are few effective therapeutic options. 

Assistant Professor Dechen Lin may just have a solution. New research conducted at Ostrow’s Center for Craniofacial Molecular Biology shows that a pathway of a particular amino acid may be critical in shutting down the growth and proliferation of oral cancers, and a specific diet could be a treatment. 

Finding the culprit

Lin started by noticing that a small amino acid called methionine is present in very high amounts in oral cancers — more than any other type of cancer tumors.  Methionine is not produced by the body, and must be consumed through diet — the molecule is found in foods like shrimp, eggs and beef. “We were just intrigued,” he says. “If something is this high, it must be very special.”

His team started to study the ways the body moves methionine around cells, through a transporter called LAT1. By blocking the transporter, the team was able to see how the pathway worked in an animal model. 

The new paper, published in the journal Proceedings of the National Academy of Sciences, also shows how methionine can be used against the growing tumors. Lin points out that most therapeutics, like chemo and radiation therapies, have been around for decades —and can come with huge side effects. 

By targeting this amino acid for future treatments — with both drugs and diet-based interventions — patients could have a much more effective treatment path.

Who is the best candidate?

Using animals and lab-grown organoids from the tissues of real patients, Lin and the team showed that a special diet lacking in methionine blocked the pathway, tumors grew much more slowly – about half of those in animals on the regular diet. “This vulnerability is specific for cancer, because the cancer cells feed on this methionine,” Lin explains. “And if we take it away, they die quickly, but normal cells do not die quickly. They don’t really care much. So that’s a perfect window.” 

Lin has been working with physicians at the Keck School of Medicine of USC on a future clinical trial that would focus on a low-methionine diet for patients with these oral cancers. The study also included Uttam Kumar Sinha, medical director of Head and Neck Surgery at the Keck School of Medicine. 

In the future, Lin said he would like to further investigate which patients might get the most benefits from interventions. “Now, we have something that’s cancer specific,” Lin explains, “which gives us hope that if we use this right, maybe we’re able to cure the cancer cells, but spare normal cells.” 


Author: Katherine Gammon

Source: https://dentistry.usc.edu/

Related articles

Amy Merrill PhD ’04 has recently received an eight-year grant from the National Institute of Dental and Craniofacial Research.


Envista Holdings Corporation and its charitable arm, the Envista Smile Project, announced today that it has partnered with the University of Southern California’s Herman Ostrow School of Dentistry...


A new NIDCR grant will give Assistant Professor Dechen Lin the opportunity to test diet and medication’s efficacy on head and neck cancer.


Lay Soon and Elissa Elmorr each took first place in the Graduate Trainee and Dental Predoctoral Oral Presentation competitions respectively at the 2025 School of Dentistry Research Day on Wednesday.


Faculty at the School of Dentistry in 2024 recorded another productive year of publishing their dental, oral and craniofacial research in numerous leading scientific journals.


Read more

The ‘hygiene hypothesis’ suggests that a reduction in the microbial exposure due to improved health measures has contributed to an immunological imbalance in the intestine and increased the...


Lay Soon and Elissa Elmorr each took first place in the Graduate Trainee and Dental Predoctoral Oral Presentation competitions respectively at the 2025 School of Dentistry Research Day on Wednesday.


vVARDIS, a Swiss high-growth dental company, and OrbiMed, a leading healthcare investment firm, recently announced the closing of a $35 million financing.


Greenland Advanced Oral Care is proud to announce the addition of Dr. Eryn Huber to its expert dental team. 


Torch Dental, a pioneering technology platform specializing in dental supply management, ordering, and budgeting, is thrilled to partner with the Sacramento District Dental Society (SDDS), an...


 
 
 
 

 
 
 
 

Most popular

 
 

Events